The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors Ming-Guo XieJiao QiaoGuoming Luan Research 02 September 2022 Pages: 1 - 12
Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018 Matthew J. ReckerCathleen C. KuoRobert J. Plunkett Research 11 July 2022 Pages: 13 - 22
Outcomes after gamma knife radiosurgery for intraventricular meningiomas Alberto Daza-OvalleOthman Bin-AlamerL. Dade Lunsford Research 26 July 2022 Pages: 23 - 31
Outcomes following surgical resection of cystic intracranial meningiomas Alan R. TangSilky ChotaiLola B. Chambless Research 03 August 2022 Pages: 33 - 40
Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors Kyung Taek HongJung Woo HanJoo-Young Kim Research 31 August 2022 Pages: 41 - 53
Surgical results of 158 petroclival meningiomas with special focus on standard craniotomies Gabriele SchackertMiriam LenkTareq A. Juratli Clinical Study Open access 14 September 2022 Pages: 55 - 65
Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p Hu SuZhao HailinPeng Biao Research 12 September 2022 Pages: 67 - 78
Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials Paolo PalmiscianoGina WatanabeRandy S. D’Amico Review 23 August 2022 Pages: 79 - 100
Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study Lisa Millgård SagbergEven Hovig FyllingenOle Solheim Research Open access 27 August 2022 Pages: 101 - 106
Frameless robot-assisted stereotactic biopsy: an effective and minimally invasive technique for pediatric diffuse intrinsic pontine gliomas Min WangYi ZhangRui Zhao Research 23 August 2022 Pages: 107 - 114
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation Satoka ShidohRicky R. SavjaniBenjamin M. Ellingson Research Open access 02 September 2022 Pages: 115 - 125
Meningioma in patients exposed to progestin drugs: results from a real-life screening program Thomas SamoyeauCorentin ProvostJoseph Benzakoun Research 06 September 2022 Pages: 127 - 136
miR-497 and 219 in blood aid meningioma classification Ahmed AbdelrahmanCaterina NegroniClemens Oliver Hanemann Research 08 September 2022 Pages: 137 - 147
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3 Jonathan WellerSophie KatzendoblerJoerg-Christian Tonn Research Open access 16 September 2022 Pages: 149 - 158
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion Henri MalaizéFlorence Laigle-Donadeythe PSL BRAIN-BIOPSY STUDY GROUP Research 09 September 2022 Pages: 159 - 170
Racial disparities in pediatric malignant glioma management: current state of affairs in the United States Victor M. LuToba N. Niazi Research 08 September 2022 Pages: 171 - 178
The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology Yasuki SurugaKaishi SatomiIsao Date Case Study 15 September 2022 Pages: 179 - 189
Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study Yutaro KoideNaoya NagaiTakeshi Kodaira Research 16 September 2022 Pages: 191 - 200
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study Chloe DumotStylianos PikisJason P. Sheehan Research 27 September 2022 Pages: 201 - 208
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017 Gino CioffiKristin A. WaiteJill S. Barnholtz-Sloan Research Open access 05 October 2022 Pages: 209 - 219
Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab Guangrong LuPing ZhuJay-Jiguang Zhu Clinical Study 06 October 2022 Pages: 221 - 231
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer Caressa HuiVera QuErqi Pollom Research 13 October 2022 Pages: 233 - 240
A quantitative characterization of the spatial distribution of brain metastases from breast cancer and respective molecular subtypes Saeedeh MahmoodifarDhiraj J. PangalPaul K. Newton Research 16 October 2022 Pages: 241 - 251
Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients Mathew PeaseZachary C. GerseyP. O. Zinn Research 14 October 2022 Pages: 253 - 263
Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis Pejman Jabehdar MaralaniHanbo ChenArjun Sahgal Research 07 October 2022 Pages: 265 - 272
Letter: Does the “hospital frailty risk score” measure preoperative frailty for craniopharyngioma surgery? Joshua MarquezMeic SchmidtChristian A. Bowers Correspondence 12 October 2022 Pages: 273 - 275
